Lipofen is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Ani Pharmaceuticals, Inc.. The primary component is Fenofibrate.
Product ID | 62559-305_25f18a1a-2283-469b-a18f-e573fa72a1ee |
NDC | 62559-305 |
Product Type | Human Prescription Drug |
Proprietary Name | Lipofen |
Generic Name | Fenofibrate |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2021-09-24 |
Marketing Category | NDA / |
Application Number | NDA021612 |
Labeler Name | ANI Pharmaceuticals, Inc. |
Substance Name | FENOFIBRATE |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-09-24 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
66869-147 | LIPOFEN | LIPOFEN |
66869-137 | LIPOFEN | LIPOFEN |
0093-7755 | Fenofibrate | Fenofibrate |
0093-7756 | Fenofibrate | Fenofibrate |
0115-0511 | Fenofibrate | FENOFIBRATE |
0115-0522 | Fenofibrate | FENOFIBRATE |
0115-0533 | Fenofibrate | FENOFIBRATE |
0115-1522 | Fenofibrate | Fenofibrate |
0115-1523 | Fenofibrate | Fenofibrate |
0115-5511 | FENOFIBRATE | FENOFIBRATE |
0115-5522 | FENOFIBRATE | FENOFIBRATE |
0074-3173 | Tricor | Fenofibrate |
0074-3189 | Tricor | Fenofibrate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LIPOFEN 78688955 3403114 Live/Registered |
Cipher Pharmaceuticals Inc. 2005-08-09 |